Last Updated: December, 2018
The Indian pharmaceuticals market is the third-largest in terms of volume and thirteenth-largest in terms of value. It has established itself as a global manufacturing and research hub. A large raw material base and the availability of a skilled workforce give the industry a definite competitive advantage. The Indian pharmaceutical industry is expected to grow at a compound annual growth rate (CAGR) of 22.4 per cent to touch US$ 55 billion by 2020.
The Indian Pharmaceutical market is dominated by generic drugs which constitutes nearly 70 per cent of the market, whereas Over the Counter (OTC) medicines and patented drugs make up to 21 per cent and 9 per cent respectively.
The Pharmaceutical Export Promotion Council (PHARMEXCIL) was established in 2004 by the Ministry of Commerce and Industry, Government of India, to promote pharma exports.
Note: * - Includes Bulk Drugs, Drug Intermediates, Drug formulations, Biologicals, Ayush and Herbal Products and Surgicals
Source:
Directorate General of Commercial Intelligence and Statistics (DGCIS)
Other Export Promotion Councils:
Disclaimer: This information has been collected through secondary research and IBEF is not responsible for any errors in the same.
101, Aditya Trade Centre
Ameerpet
Hyderabad - 500038
Andhra Pradesh
India
Tel.:+91-40-23735462/66
Fax: +91-40-23735464
Email: info@pharmexcil.com
Website: www.pharmexcil.com
Source:
Directorate General of Commercial Intelligence and Statistics (DGCIS)
Pharmaceutical